MX:Medtech Executive Features
Jan 19, 2012
The United States entered a new phase of patent harmonization when the America Invents Act (AIA) was signed into law in September 2011. As a result of AIA...
Jan 19, 2012
In the competitive medtech IP environment, a strong patent position may represent the lifeblood of a company. To attain that position, a medical device company...
Jan 19, 2012
During his years leading drug-development efforts at major biomed companies, David Parkinson says his frustration mounted as the industry couldn’t quite...
Dec 14, 2011
Over the past several years, the medical device industry has been rocked by product recalls, U.S. Department of Justice investigations into improper marketing...
Dec 14, 2011
Reversing a lower court ruling, a U.S. appeals court determined in July 2011 that isolated DNA can be patented. The ruling in Myriad Genetics by the Court of...
Dec 14, 2011
Thirteen years in sales management at Sofamor Danek taught Skip Goode the value of making sure that employees understand how their individual skills contribute...
Nov 29, 2011
Introduction Character is like a tree and reputation like a shadow. The shadow is what we think of it; the tree is the real thing. —Abraham Lincoln What...
Nov 18, 2011
Isis Biopolymer has decided that the smoothest path to developing its “intelligent” transdermal patch technology is by treating wrinkles. And the...
Nov 17, 2011
A disciplined business case is the key to expanding market share and establishing strategic competitive advantage. The complexity and significant cost of...
Nov 17, 2011
Patent reform became a reality on September 16, 2011, with the enactment of the Leahy-Smith America Invents Act. While President Obama and the U.S. Patent and...